Staphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy

Staphylococccus aureus represents one of the most challenging human pathogens as well as a common colonizer of human skin and mucosal surfaces. S. aureus causes a wide range of diseases from skin and soft tissue infection (SSTI) to debilitating and life-threatening conditions such as osteomyelitis, endocarditis, and necrotizing pneumonia. The range of diseases reflects the remarkable diversity of the virulence factors produced by this pathogen, including surface antigens involved in the establishment of infection and a large number of toxins that mediate a vast array of cellular responses. The staphylococcal toxins are generally believed to have evolved to disarm the innate immune system, the first line of defense against this pathogen. This review focuses on recent advances on elucidating the biological functions of S. aureus bicomponent pore-forming toxins (BCPFTs) and their utility as targets for preventive and therapeutic intervention. These toxins are cytolytic to a variety of immune cells, primarily neutrophils, as well as cells with a critical barrier function. The lytic activity of BCPFTs towards immune cells implies a critical role in immune evasion, and a number of epidemiological studies and animal experiments relate these toxins to clinical disease, particularly SSTI and necrotizing pneumonia. Antibody-mediated neutralization of this lytic activity may provide a strategy for development of toxoid-based vaccines or immunotherapeutics for prevention or mitigation of clinical diseases. However, certain BCPFTs have been proposed to act as danger signals that may alert the immune system through an inflammatory response. The utility of a neutralizing vaccination strategy must be weighed against such immune-activating potential.

• Publication year

  2014

• Venue

  Toxins

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/toxins6030950PMID 24599233PMCID 3968370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lancet

  2021cited by this paper
• A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.

  2013cited by this paper
• Clearance of Staphylococcus aureus Nasal Carriage Is T Cell Dependent and Mediated through Interleukin-17A Expression and Neutrophil Influx

  2013cited by this paper
• Activation of neutrophils by the two-component leukotoxin LukE/D from Staphylococcus aureus: proteomic analysis of the secretions.

  2013influential reference
• Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.

  2013cited by this paper
• The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis

  2013cited by this paper
• Role of Pore-Forming Toxins in Bacterial Infectious Diseases

  2013cited by this paper
• Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection.

  2013influential reference
• Staphylococcus aureus Leukotoxin GH Promotes Formation of Neutrophil Extracellular Traps

  2013cited by this paper
• The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.

  2013influential reference
• Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue

  2013cited by this paper
• Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology.

  2013cited by this paper
• Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model

  2013influential reference
• Children with Invasive Staphylococcus aureus Disease Exhibit a Potently Neutralizing Antibody Response to the Cytotoxin LukAB

  2013cited by this paper
• Neutrophils versus Staphylococcus aureus: a biological tug of war.

  2013cited by this paper
• Identification of a Crucial Residue Required for Staphylococcus aureus LukAB Cytotoxicity and Receptor Recognition

  2013cited by this paper
• Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.

  2013cited by this paper
• Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1

  2013influential reference
• Prevalence of Clonal Complexes and Virulence Genes among Commensal and Invasive Staphylococcus aureus Isolates in Sweden

  2013cited by this paper
• Staphylococcus aureus leukotoxin GH promotes inflammation.

  2012cited by this paper
• CCR5 is a receptor for Staphylococcus aureus leukotoxin ED

  2012influential reference
• Immune-Activating Properties of Panton-Valentine Leukocidin Improve the Outcome in a Model of Methicillin-Resistant Staphylococcus aureus Pneumonia

  2012cited by this paper
• A comparison of the endotoxin biosynthesis and protein oxidation pathways in the biogenesis of the outer membrane of Escherichia coli and Neisseria meningitidis

  2012cited by this paper
• Identification of Anti-Alpha Toxin Monoclonal Antibodies That Reduce the Severity of Staphylococcus aureus Dermonecrosis and Exhibit a Correlation between Affinity and Potency

  2012cited by this paper
• Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome.

  2012cited by this paper
• Staphylococcus aureus Hemolysins, bi-component Leukocidins, and Cytolytic Peptides: A Redundant Arsenal of Membrane-Damaging Virulence Factors?

  2012cited by this paper
• Sublytic concentrations of Staphylococcus aureus Panton‐Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity

  2012cited by this paper
• Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo

  2012cited by this paper
• Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections.

  2012influential reference
• Host Response Signature to Staphylococcus aureus Alpha-Hemolysin Implicates Pulmonary Th17 Response

  2012cited by this paper
• ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin.

  2012cited by this paper
• Cross‐talk between Staphylococcus aureus leukocidins‐intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome‐dependent manner

  2012cited by this paper
• Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins

  2011influential reference
• Purified Staphylococcus aureus leukotoxin LukM/F' does not trigger inflammation in the bovine mammary gland.

  2011cited by this paper
• Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 study.

  2011cited by this paper
• Global Changes in Staphylococcus aureus Gene Expression in Human Blood

  2011influential reference
• Staphylococcal Panton-Valentine Leucocidin as a Major Virulence Factor Associated to Furuncles

  2011cited by this paper
• Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis

  2011influential reference
• Development of a vaccine against Staphylococcus aureus

  2011cited by this paper
• TLR 2 and CD14 Mediate Innate Immunity and Lung Inflammation to Staphylococcal Panton–Valentine Leukocidin In Vivo

  2011cited by this paper
• Staphylococcus aureus survival in human blood

  2011cited by this paper
• Inhibiting the C5-C5a receptor axis.

  2011cited by this paper
• Panton-Valentine Leukocidin Does Play a Role in the Early Stage of Staphylococcus aureus Skin Infections: A Rabbit Model

  2011cited by this paper
• Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection

  2010cited by this paper
• High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.

  2010cited by this paper
• Identification of a Novel Staphylococcus aureus Two-Component Leukotoxin Using Cell Surface Proteomics

  2010influential reference
• Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils

  2010influential reference
• Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus.

  2010influential reference
• Structural Model of the Pre-pore Ring-like Structure of Panton-Valentine Leukocidin: Providing Dimensionality to Biophysical and Mutational Data

  2010cited by this paper
• Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates.

  2010cited by this paper
• Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury

  2010influential reference
• Staphylococcus aureus toxin gene hitchhikes on a transferable antibiotic resistance element

  2010influential reference
• A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus

  2010cited by this paper
• Staphylococcus aureus Panton-Valentine Leukocidin Contributes to Inflammation and Muscle Tissue Injury

  2009cited by this paper
• Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A2

  2009cited by this paper
• Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin.

  2009cited by this paper
• Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia

  2009cited by this paper
• Contribution of Panton-Valentine Leukocidin in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis

  2008cited by this paper
• Analysis of the Specificity of Panton-Valentine Leucocidin and Gamma-Hemolysin F Component Binding

  2008cited by this paper
• The role of virulence determinants in community-associated MRSA pathogenesis.

  2008cited by this paper
• Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3

  2008cited by this paper
• Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia

  2007cited by this paper
• Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets.

  2007cited by this paper
• Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus.

  2007cited by this paper
• Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.

  2006influential reference
• Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections

  2006cited by this paper
• Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

  2006cited by this paper
• Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.

  2006cited by this paper
• Methicillin-resistant S. aureus infections among patients in the emergency department.

  2006cited by this paper
• Staphylococcus aureus leucocidin, a virulence factor in bovine mastitis.

  2005cited by this paper
• Emergence of Virulent Methicillin-Resistant Staphylococcus aureus Strains Carrying Panton-Valentine Leucocidin Genes in The Netherlands

  2005cited by this paper
• The leukocidin pore: Evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis

  2005cited by this paper
• Phagocytosis: elegant complexity.

  2005influential reference
• Evidence for a functional role of the second C5a receptor C5L2

  2005cited by this paper
• Staphylococcus aureus Bicomponent gamma-Hemolysins, HlgA, HlgB, and HlgC, Can Form Mixed Pores Containing All Components

  2005influential reference
• Bacterial Two-component and Hetero-heptameric Pore-forming Cytolytic Toxins: Structures, Pore-forming Mechanism, and Organization of the Genes

  2004influential reference
• Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent

  2004cited by this paper
• Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus.

  2004cited by this paper
• Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

  2003cited by this paper
• Purification, Cloning and Characterization of Variant LukE‐LukD with Strong Leukocidal Activity of Staphylococcal Bi‐Component Leukotoxin Family

  2003influential reference
• Global repression of exotoxin synthesis by staphylococcal superantigens

  2002cited by this paper
• Subunit composition of a bicomponent toxin: Staphylococcal leukocidin forms an octameric transmembrane pore

  2002cited by this paper
• Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

  2002cited by this paper
• Staphylococcus aureus Isolated in Cases of Impetigo Produces Both Epidermolysin A or B and LukE-LukD in 78% of 131 Retrospective and Prospective Cases

  2001cited by this paper
• Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT.

  2001cited by this paper
• Prolonged course of toxic shock syndrome associated with methicillin-resistant Staphylococcus aureus enterotoxins G and I.

  2001cited by this paper
• Characterization of leukocytotoxic and superantigen-like factors produced by Staphylococcus aureus isolates from milk of cows with mastitis.

  2001cited by this paper
• Flow Cytometric Determination of Panton-Valentine Leucocidin S Component Binding

  2001influential reference
• Prophage, φPV83-pro, Carrying Panton-Valentine Leukocidin Genes, on the Staphylococcus aureus P83 Chromosome: Comparative Analysis of the Genome Structures of φPV83-pro, φPVL, φ11, and Other Phages

  2000cited by this paper
• Prophage, phiPV83-pro, carrying panton-valentine leukocidin genes, on the Staphylococcus aureus P83 chromosome: comparative analysis of the genome structures of phiPV83-pro, phiPVL, phi11, and other phages.

  2000cited by this paper
• Staphylococcal α Toxin

  2000cited by this paper
• Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

  1999cited by this paper
• Crystal structure of Staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel

  1999cited by this paper
• Predominant Staphylococcus aureusIsolated from Antibiotic-Associated Diarrhea Is Clinically Relevant and Produces Enterotoxin A and the Bicomponent Toxin LukE-LukD

  1999cited by this paper
• Assembly of Staphylococcus aureus leukocidin into a pore-forming ring-shaped oligomer on human polymorphonuclear leukocytes and rabbit erythrocytes.

  1999cited by this paper
• The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins.

  1999cited by this paper
• Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes.

  1998cited by this paper
• Toxins

  1998cited by this paper
• Characterization of a novel structural member, LukE‐LukD, of the bi‐component staphylococcal leucotoxins family

  1998cited by this paper
• The Staphylococcal Pore-forming Leukotoxins Open Ca2+ Channels in the Membrane of Human Polymorphonuclear Neutrophils

  1998cited by this paper

• Influence of bacterial proteins on the host’s cell cycle

  2025cites this paper
• Whole genome sequencing based prediction of antimicrobial resistance evolution among the predominant bacterial pathogens of diabetic foot ulcer

  2025cites this paper
• Duffy Antigen Receptor for Chemokines (DARC) Nanodisc-Based Biosensor for Detection of Staphylococcal Bicomponent Pore-Forming Leukocidins.

  2024cites this paper
• Contribution of staphylococcal virulence factors in the pathogenesis of thrombosis.

  2024cites this paper
• Using Targeted Nano-Antibiotics to Improve Antibiotic Efficacy against Staphylococcus aureus Infections

  2023cites this paper
• Natural Antibacterial Agent-based Nanoparticles for Effective Treatment of Intracellular MRSA Infection.

  2023cites this paper
• Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models

  2022cites this paper
• Staphylococcus aureus adaptive evolution: Recent insights on how immune evasion, immunometabolic subversion and host genetics impact vaccine development

  2022cites this paper
• A comprehensive and mechanistic review on protective effects of kaempferol against natural and chemical toxins: Role of NF‐κB inhibition and Nrf2 activation

  2022cites this paper
• Molecular epidemiology, virulence and antimicrobial resistance of Bulgarian methicillin resistant Staphylococcus aureus isolates.

  2022cites this paper
• Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralization

  2022cites this paper
• Expression of Staphylococcal Virulence Genes In Situ in Human Skin and Soft Tissue Infections

  2022cites this paper
• Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques

  2021cites this paper
• Kaempferol inhibits the expression of α-hemolysin and protects mice from methicillin-resistant Staphylococcus aureus-induced lethal pneumonia.

  2021cites this paper
• Characterizing human receptor-mediated cytotoxicity by staphylococcal bi-component leucocidins in S. aureus pathogenesis

  2021influential citation
• IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus

  2021cites this paper
• Alternative Anti-Infective Treatments to Traditional Antibiotherapy against Staphylococcal Veterinary Pathogens

  2020cites this paper
• Efficacy of Active Immunization with Attenuated Alpha-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.

  2019cites this paper
• Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)

  2019influential citation
• Corrélation des gènes de résistance à la méthicilline et de virulence de Staphylococcus aureus avec les types d ' infection et le mode d ' acquisition à

  2019cites this paper
• Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms

  2019influential citation
• Molecular-genetic Method for Fast Direct Detection of Staphylococcus Aureus and Methicillin Resistance in Blood Cultures and Punctures.

  2019cites this paper
• Genetics of bi-component leukocidin and drug resistance in nasal and clinical Staphylococcus aureus in Lagos, Nigeria.

  2018cites this paper
• Quercetin, a secondary metabolite present in methanolic extract of Calendula officinalis, is a potent inhibitor of peptide deformylase, undecaprenyl pyrophosphate synthase and DNA primase enzymes of Staphylococcus aureus: an in vitro and in silico result analysis

  2018cites this paper
• Immune and Inflammatory Reponses to Staphylococcus aureus Skin Infections

  2018cites this paper
• Antibiotics Resistance Profile of Staphylococci Isolated from Urogenital Infections and Toxins Production ofStaphylococcus aureus Strains

  2018cites this paper
• A Critical Role for HlgA in Staphylococcus aureus Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System

  2018cites this paper
• Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors

  2017cites this paper
• Relationships among superantigen toxin gene profiles, genotypes, and pathogenic characteristics of Staphylococcus aureus isolates from bovine mastitis.

  2017cites this paper
• Corrigendum: Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections

  2017cites this paper
• Cloning and Expression of Alpha Hemolysin Toxin Gene of Staphylococcus aureus Against Human Cancer Tissue

  2017cites this paper
• Vaccines for Staphylococcus aureus and Target Populations.

  2017cites this paper
• Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections

  2017cites this paper
• Selective sensitization of human neutrophils to LukGH mediated cytotoxicity by Staphylococcus aureus and IL-8.

  2017cites this paper
• Staphylococcus aureus δ-toxin in aqueous solution: Behavior in monomeric and multimeric states.

  2017cites this paper
• Prevalence of bi-component pore-forming toxin genotypes of Staphylococcus aureus causing skin and soft tissue infections

  2017cites this paper
• Nanoparticle‐Based Antivirulence Vaccine for the Management of Methicillin‐Resistant Staphylococcus aureus Skin Infection

  2016cites this paper
• Exploiting dominant‐negative toxins to combat Staphylococcus aureus pathogenesis

  2016cites this paper
• Recent developments for Staphylococcus aureus vaccines: clinical and basic science challenges.

  2015cites this paper
• Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs

  2015cites this paper
• Methicillin-resistant Staphylococcus aureus colonization and infection risks from companion animals: current perspectives

  2015cites this paper
• Five birds, one stone: Neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody

  2014cites this paper
• Structure-Function Analysis of Heterodimer Formation, Oligomerization, and Receptor Binding of the Staphylococcus aureus Bi-component Toxin LukGH*

  2014cites this paper
• staphylococ-Relationships among superantigen toxin gene profiles, genotypes, and pathogenic characteristics of Staphylococcus aureus isolates from bovine mastitis

  year unknowncites this paper